Rank last year: 14
Brad Vale has been with US-based healthcare company Johnson & Johnson’s corporate venturing unit Johnson & Johnson Development Corporation (JJDC) since 1992. In 1997 he moved to California to establish its Silicon Valley office.
In 2008, Vale was made head of venture investments and, in 2012, he took over as head of JJDC to continue the venture support to J&J’s operating units and expand its early stage activities in collaboration with J&J’s Innovation Centers in London, Boston, California, and Shanghai. He is based in Silicon Valley, California.
Before joining JJDC, he previously supported Johnson & Johnson’s medical device businesses in J&J’s Corporate Office of Science and Technology and from 1982 to 1989, and he was at Ethicon, a Johnson & Johnson subsidiary, working in research and development and product development in wound closure, vascular prostheses, adhesion prevention and lasers in surgery. Vale received a PhD in biomedical engineering from Iowa State University and is a Washington State University doctor of veterinary medicine.